These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28119542)

  • 1. Dephosphorylation of Y685-VE-Cadherin Involved in Pulmonary Microvascular Endothelial Barrier Injury Induced by Angiotensin II.
    Wu Z; Wang Z; Dai F; Liu H; Ren W; Chang J; Li B
    Mediators Inflamm; 2016; 2016():8696481. PubMed ID: 28119542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VE-cadherin involved in the pulmonary microvascular endothelial cell barrier injury induced by angiotensin II through modulating the cellular apoptosis and skeletal rearrangement.
    Wu Z; Liu H; Ren W; Dai F; Chang J; Li B
    Am J Transl Res; 2016; 8(10):4310-4319. PubMed ID: 27830014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of VE-Cadherin in Hypoxia Induced Injury of Pulmonary Microvascular Endothelial Barrier.
    Zhong L; Gao X; Chen Y; Yu Z; Jin S; Zhu C
    Heart Surg Forum; 2021 Aug; 24(4):E764-E768. PubMed ID: 34473045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p18, a novel adaptor protein, regulates pulmonary endothelial barrier function via enhanced endocytic recycling of VE-cadherin.
    Chichger H; Duong H; Braza J; Harrington EO
    FASEB J; 2015 Mar; 29(3):868-81. PubMed ID: 25404710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organs.
    Sidibé A; Polena H; Pernet-Gallay K; Razanajatovo J; Mannic T; Chaumontel N; Bama S; Maréchal I; Huber P; Gulino-Debrac D; Bouillet L; Vilgrain I
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H455-63. PubMed ID: 24858856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium.
    Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC
    Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiopulmonary bypass increases pulmonary microvascular permeability through the Src kinase pathway: Involvement of caveolin-1 and vascular endothelial cadherin.
    Zhang J; Jiang Z; Bao C; Mei J; Zhu J
    Mol Med Rep; 2016 Mar; 13(3):2918-24. PubMed ID: 26847917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
    Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
    Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VE-cadherin status as an indicator of microvascular permeability.
    Monaghan-Benson E; Burridge K
    Methods Mol Biol; 2013; 1046():335-42. PubMed ID: 23868598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury.
    Chen Q; Yi B; Ma J; Ning J; Wu L; Ma D; Lu K; Gu J
    Oncotarget; 2016 Aug; 7(35):55990-56001. PubMed ID: 27463003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.
    Adam AP; Sharenko AL; Pumiglia K; Vincent PA
    J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin.
    Ninchoji T; Love DT; Smith RO; Hedlund M; Vestweber D; Sessa WC; Claesson-Welsh L
    Elife; 2021 Apr; 10():. PubMed ID: 33908348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rab5-mediated VE-cadherin internalization regulates the barrier function of the lung microvascular endothelium.
    Yang J; Yao W; Qian G; Wei Z; Wu G; Wang G
    Cell Mol Life Sci; 2015 Dec; 72(24):4849-66. PubMed ID: 26112597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference With ESAM (Endothelial Cell-Selective Adhesion Molecule) Plus Vascular Endothelial-Cadherin Causes Immediate Lethality and Lung-Specific Blood Coagulation.
    Duong CN; Nottebaum AF; Butz S; Volkery S; Zeuschner D; Stehling M; Vestweber D
    Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):378-393. PubMed ID: 31826650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Src in Vascular Hyperpermeability Induced by Advanced Glycation End Products.
    Zhang W; Xu Q; Wu J; Zhou X; Weng J; Xu J; Wang W; Huang Q; Guo X
    Sci Rep; 2015 Sep; 5():14090. PubMed ID: 26381822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor protein tyrosine phosphatase micro regulates the paracellular pathway in human lung microvascular endothelia.
    Sui XF; Kiser TD; Hyun SW; Angelini DJ; Del Vecchio RL; Young BA; Hasday JD; Romer LH; Passaniti A; Tonks NK; Goldblum SE
    Am J Pathol; 2005 Apr; 166(4):1247-58. PubMed ID: 15793303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II induces apoptosis of human pulmonary microvascular endothelial cells in acute aortic dissection complicated with lung injury patients through modulating the expression of monocyte chemoattractant protein-1.
    Wu Z; Dai F; Ren W; Liu H; Li B; Chang J
    Am J Transl Res; 2016; 8(1):28-36. PubMed ID: 27069537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sevoflurane prevents lipopolysaccharide-induced barrier dysfunction in human lung microvascular endothelial cells: Rho-mediated alterations of VE-cadherin.
    Huang Y; Tan Q; Chen R; Cao B; Li W
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):119-24. PubMed ID: 26529544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic phosphorylation of VE-cadherin Y685 throughout mouse estrous cycle in ovary and uterus.
    Sidibé A; Polena H; Razanajatovo J; Mannic T; Chaumontel N; Bama S; Maréchal I; Huber P; Gulino-Debrac D; Bouillet L; Vilgrain I
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H448-54. PubMed ID: 24858855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase D2 restores endothelial barrier function by promoting PTPN14-mediated VE-cadherin dephosphorylation.
    Fu P; Ramchandran R; Shaaya M; Huang L; Ebenezer DL; Jiang Y; Komarova Y; Vogel SM; Malik AB; Minshall RD; Du G; Tonks NK; Natarajan V
    J Biol Chem; 2020 May; 295(22):7669-7685. PubMed ID: 32327488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.